Aims and Scope of Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Mycobacterial Diseases aims to provide a forum for clinically relevant articles on all aspects of tuberculosis and other mycobacterial infections, including (but not limited to) epidemiology, clinical investigation, transmission, diagnosis, treatment, drug-resistance and public policy, and encourages the submission of clinical studies, thematic reviews and case reports. Journal of Clinical Tuberculosis and Mycobacterial Diseases is an Open Access publication. Less
Key Metrics
CiteScore 

2.5
SJR 

Q3Infectious Diseases

SNIP 

0.89
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 1860 |
| Publication Time | 30 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Prevalence of Long COVID in Mycobacterium tuberculosis-exposed groups.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Development of a diagnostic nomogram for tuberculous pleural effusion.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Comment on "Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: A retrospective cohort study".
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Association of vitamin D receptor TaqI gene polymorphism and vitamin D deficiency with risk of pulmonary tuberculosis in the Ethiopian population.
- 1 May 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Silent barriers: psycho-social factors and the hidden risk of medication non-adherence among tuberculosis patients in Mongolia.
- 1 May 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Prevalence of Long COVID in Mycobacterium tuberculosis-exposed groups.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Development of a diagnostic nomogram for tuberculous pleural effusion.
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Comment on "Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: A retrospective cohort study".
- 1 Aug 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Association of vitamin D receptor TaqI gene polymorphism and vitamin D deficiency with risk of pulmonary tuberculosis in the Ethiopian population.
- 1 May 2026
- Journal of clinical tuberculosis and other mycobacterial diseases
Silent barriers: psycho-social factors and the hidden risk of medication non-adherence among tuberculosis patients in Mongolia.
- 1 May 2026
- Journal of clinical tuberculosis and other mycobacterial diseases